Previous Close | 10.23 |
Open | 10.53 |
Bid | 0.00 x 1100 |
Ask | 0.00 x 900 |
Day's Range | 10.53 - 10.53 |
52 Week Range | 10.05 - 10.53 |
Volume | |
Avg. Volume | 1,644 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for OTECU
NEW YORK, August 10, 2022--Captura Biopharma, an emerging biotechnology company developing and commercializing oral chelators to treat internal transuranic radionuclide contamination and heavy metal poisoning, and OceanTech Acquisitions I Corp. ("OceanTech") (Nasdaq: OTEC/OTECU and OTECW), a special purpose acquisition company, today announced that they have entered into a definitive business combination agreement (the "Merger Agreement") that will result in Captura Biopharma becoming a publicly
NEW YORK, June 02, 2022--OceanTech Acquisitions I Corp. ("OceanTech" or the "Company") (Nasdaq: OTECU), a special purpose acquisition company, today announced that it has caused to be deposited $1,548,900 into the Company’s Trust account for its public stockholders, representing $0.15 per public share, allowing the Company to extend the period of time it has to consummate its initial business combination by six months from June 2, 2022 to December 2, 2022 (the "Extension"). The Extension is perm
NEW YORK, May 23, 2022--OceanTech Acquisitions I Corp. ("OceanTech" or the "Company") (Nasdaq: OTECU), a special purpose acquisition company, today announced that it will extend the period of time it has to consummate its initial business combination by six months from June 2, 2022 to December 2, 2022 (the "Extension"). OceanTech Acquisitions I Sponsors LLC (the "Sponsor"), has notified the Company that it intends to purchase 1,548,900 private placement warrants at $1.00 per warrant by depositin